Robert Pitts, MD MPH

Assistant Professor
NYU Langone Health

Disclosure(s): Gilead Inc: Advisor/Consultant; ViiV: Advisor/Consultant

Poster(s):

• (P-218) Examining CD4, Viral Load and STI Co-Infection as Predictors of Severe Mpox Outcomes Among a Cohort of People with HIV in New York City
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-308) Understanding Recruitment into a Long-acting Injectable Pre-exposure Prophylaxis Trial: Lessons Learned to Enhance Equity and Optimize Engagement of Underserved Groups
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-323) Examining Preliminary Adherence to Long-Acting Injectable Pre-Exposure Prophylaxis (LAI-PrEP) among Racial, Sexual, and Gender Minority Populations at NYC Health+Hospitals/Bellevue: The EquiPrEP Study
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-329) Leveraging Hospital-Community Partnerships to Support Equitable Access and Adherence to Long-acting Injectable PrEP (LAI-PrEP) at a NYC Safety-Net Hospital: Findings from the EquiPrEP Study
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-2072) Sociodemographics and Viral Load Outcomes of People Newly Diagnosed with HIV or Returning to HIV Care Receiving RapidTx Cards at NYC Health+Hospitals/Bellevue
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET